Hormone holds potential of keeping joint injuries from causing long-term OsteoarthritisAn existing drug for osteoporosis, Teriparitide, has been found as the first drug to prevent loss of cartilage from osteoarthritis after an incident of joint injury. This drug is also capable of regenerating a portion of cartilage lost because of osteoarthritis.

These findings were reported at the annual meeting of the American Society for Bone and Mineral Research in Denver.

This study was funded by the National Institutes of Health and conducted by Randy Rosier, M.D., Ph.D., professor within the Department of Orthopaedics and Rehabilitation at the University of Rochester Medical Center in collaboration with Erik Sampson, Todd O’Brien, Di Chen, Susan Bukata, J. Edward Puzas, Regis O’Keefe and Michael Zuscik within the Department of Orthopaedics and by Hani Awad in the Department of Biomedical Engineering at the University of Rochester Medical Center.

Comments

comments